TACHYBAN
Brand Name: TACHYBAN
Generic Name: Adenosine
Active
Registration Number
DRP-9230
Dosage Form
Solution For Injection (I.V)
Issuance Date
June 17, 2025
Expiry Date
October 15, 2037
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength3 mg / mL
Packaging2 mL flint USP Type I ampoule with red OPC in
plastic tray (each ampoule packed in monocarton) (Box of 5's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Cardiac Therapy (Other Cardiac Preparation)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
AdenosineActive
Monograph: Adenosine